| Joshua Adam Earl, MD | |
|
1812 N Mills Ave, Orlando, FL 32803-1834 | |
| (407) 897-3499 | |
| (407) 896-9454 |
| Full Name | Joshua Adam Earl |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 8 Years |
| Location | 1812 N Mills Ave, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053767806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME148751 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Medical Group Inc | 0749186153 | 1163 |
News Archive
Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
Peripheral artery disease (PAD) is a major cause of limb loss. It is estimated that PAD affects between 8.5 and 12 million Americans, with a prevalence that has increased by about 25 percent over the preceding decade.
Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.
United BioSource Corporation (UBC), a global scientific and medical affairs organization, today announced that it had secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.
› Verified 8 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
Peripheral artery disease (PAD) is a major cause of limb loss. It is estimated that PAD affects between 8.5 and 12 million Americans, with a prevalence that has increased by about 25 percent over the preceding decade.
Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.
United BioSource Corporation (UBC), a global scientific and medical affairs organization, today announced that it had secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Adam Earl, MD 1812 N Mills Ave, Orlando, FL 32803-1834 Ph: (407) 897-3499 | Joshua Adam Earl, MD 1812 N Mills Ave, Orlando, FL 32803-1834 Ph: (407) 897-3499 |
News Archive
Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
Peripheral artery disease (PAD) is a major cause of limb loss. It is estimated that PAD affects between 8.5 and 12 million Americans, with a prevalence that has increased by about 25 percent over the preceding decade.
Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.
United BioSource Corporation (UBC), a global scientific and medical affairs organization, today announced that it had secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.
› Verified 8 days ago
Robert Anthony Badalament, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-897-3499 Fax: 407-896-9454 | |
Nabil Hilwa, MD Urology Medicare: Medicare Enrolled Practice Location: 7301 Stonerock Cir, Orlando, FL 32819 Phone: 407-298-6950 Fax: 407-578-2354 | |
Dr. George Frederick Ellis, MD Urology Medicare: Medicare Enrolled Practice Location: 89 W Copeland Dr, Orlando, FL 32806 Phone: 321-842-6910 Fax: 321-843-5998 | |
Albert Michael Ong, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 41 W Kaley St, Orlando, FL 32806 Phone: 407-843-6645 Fax: 407-843-4519 | |
Jason Cheng-en Sea, MD, FRCSC Urology Medicare: Accepting Medicare Assignments Practice Location: 2101 Park Center Dr Ste 130, Orlando, FL 32835 Phone: 407-298-6950 Fax: 407-578-2354 | |
Dr. Lucas Ross Wiegand, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 303 E Par St, Orlando, FL 32804 Phone: 877-876-3627 Fax: 321-843-4101 |